Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

View:
Post by davewho on Jul 08, 2021 8:09pm

SZLS

The AVRT  Program

AVRT™ is a comprehensive telehealth program that uses advanced diagnostics, evidence based clinical protocols and online physician supervision to help patients stay well and reduce the risk of developing cancer and other chronic diseases. AVRT is run by The Care Oncology Group, a team of experienced doctors and cancer specialists who can help you understand early warning signals for cancer and chronic diseases.
StageZero Life Sciences - StageZero Life Sciences Health Solutions
Interventions to Help Keep You Well - StageZero Life Sciences
Comment by capebretongirl on Jul 08, 2021 8:35pm
I like the looks of this and believe we are making headway - however the challenge of reality creeps in. Who will use CARE and the AVRT program in the US (50 states) outside of the approximate 5000 patients already seen?  How will they discover this program once they fear they have cancer?  Why will they choose it over their current Doctor? The challenge equally exists with the other ...more  
Comment by davewho on Jul 08, 2021 9:19pm
IMO we will only see a major ramp up of marketing for Aristotle when the Care deal is signed and its actually a done deal. That should be known very very soon. Until then the s/p will be stuck at this level. Buy/hold if you believe. Sell if you don't. Simple really.
Comment by AugustLion on Jul 08, 2021 11:27pm
IT department I dont know.. its July 8th and their site still shows this Important Note for Holiday Travelers Requiring COVID-19 Testing  Please keep these dates in mind when scheduling your appointments for travel. U.S. Travelers FedEx is closed Monday, July 5th in observance of Independence Day.  Therefore, COVID-19 testing is not offered on Saturday, July 3rd or Monday ...more  
Comment by davewho on Jul 09, 2021 9:19am
Aristotle now listed on the Cancer testing drop down menu. Our Story - StageZero Life Sciences  Szls sure acting like Care is a go. Will Care do the marketing or Stage or both?
Comment by Nailbiter1 on Jul 09, 2021 9:49am
This post has been removed in accordance with Community Policy
Comment by davewho on Jul 09, 2021 10:10am
Thanks would still be nice to see it official in a NR and then front and center on Care's websites. I expect both will happen shortly.
Comment by Liked2Think on Jul 10, 2021 8:12pm
Why would they choose California for it to be "initially available" Why would they not choose somewhere like Richmond. Yes there is more people in California but doesnt it make more sense for them to do it close to home.  They have the drive up covid testing at their lab wouldnt it make sense to control the entire process at the start in house?
Comment by davewho on Jul 10, 2021 9:27pm
no, why did Care choose CA in the US to set up practice? Because, thats where the money is and thats where more people are health conscious. If you can't sell a health product in CA then unlikely you can sell it eslewhere in the US. Households in California have a median annual income of $75,277, which is more than the median annual income of  ...more  
Comment by Nailbiter1 on Jul 10, 2021 11:48pm
This post has been removed in accordance with Community Policy
Comment by Liked2Think on Jul 11, 2021 11:39pm
Maybe a better question since I am labeled as dumb but the pumpers have been telling everyone to buy since it was still above a dollar are the geniuses. Why is it only available in California and why only now seeing how Aristotle was "launched" in April?  Thats proof Aristotle wasnt launched in April so chalk that up to yet another lie we were fed. its telehealth.  Why isnt ...more  
Comment by gojotv! on Jul 12, 2021 3:21am
Hey, dum-dum, SZLS stated repeatedly that Care Oncology were getting first dibs at Aristotle before it was launched to the wider market. So, that means that existing patients in the U.S. and U.K. have been tested, which is consistent with Tripp's assertion in interview, and with Rebecca's surprise at the low estimate of this year's sales by our eResearch analyst. This has all been ...more  
Comment by Liked2Think on Jul 12, 2021 9:38am
so they "launched" aristotle April 1, but they didnt launch it then.  you make it sound as if Care was getting something no one else could get.  news flash no one else wanted it.  They need Care to try and sell this thing to the current customers they had in the hopes some other company will view it as a success.  They arent getting something exclusive. We are ...more  
Comment by Mykndrsn on Jul 12, 2021 10:06am
And you wonder why people think you're stupid. 
Comment by Mykndrsn on Jul 11, 2021 11:03am
The concept of telehealth has baffled L2T. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities